Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11527761.
- Also identified by PMC identifier 1446784.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Project ACHIEVE, which conducts HIV prevention research studies, maintains a women's site in the South Bronx in NewYork City. Owing to a focused retention effort at the South Bronx site, high retention rates were achieved in a vaccine preparedness study for women at high risk of HIV infection. Comparable retention rates have been achieved in HIV vaccine trials with similar cohorts of women at this site. These results suggest that concerns about retaining hard-to-reach populations should not cause these populations to be excluded from HIV vaccine and prevention trials.
Medical subject headings
- AIDS Vaccines
- HIV Infections
- Patient Compliance
- Patient Selection
- Public Health Practice
- Urban Health Services
- Women's Health Services